The goal of treatment — is to reduce the activity of inflammation, relieve pain and stiffness, preserve joint mobility, and prevent their further damage. The therapy regimen is selected individually.
The patient may be prescribed:
-
anti-inflammatory drugs — help to reduce pain, stiffness, and swelling in the short term;
-
drugs for controlling the immunoinflammatory process — are used to restrain the progression of the disease and reduce the risk of joint damage;
-
modern immunomodulating drugs — may be prescribed in an active course of the disease if the previous treatment does not give a sufficient effect;
-
local treatment of skin manifestations — is used for rashes, itching, skin irritation, or nail changes.
According to the recommendations of EULAR, nonsteroidal anti-inflammatory drugs may be used short-term in a mild course of psoriatic arthritis, and in peripheral joint involvement, early initiation of basic therapy, in particular with methotrexate, is recommended. If disease activity persists, biological or targeted drugs that act on individual mechanisms of the inflammatory process may be considered.
Separately, the doctor may recommend physical rehabilitation: exercises to maintain mobility, stretching, strengthening muscles, and reducing stiffness. The load is selected so as to maintain joint function, but not to provoke increased pain or swelling.